Reply to: Off-label use of repurposed ivermectin for SARS-Cov-2 infection should be banned by authorities unless efficacy is proven.

Q3 Nursing

Malaysian Family Physician Pub Date : 2024-07-17 eCollection Date: 2024-01-01 DOI:10.51866/lte.671

Abdul Jalil Aina Amanina, Tar'ali Filza Nur Athirah

引用次数: 0

查看原文本刊更多论文

答复除非疗效得到证实，否则有关当局应禁止在标签外使用改变用途的伊维菌素治疗 SARS-Cov-2 感染。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Malaysian Family Physician Medicine-Family Practice

CiteScore

1.20

自引率

0.00%

发文量

审稿时长

24 weeks

期刊介绍： The Malaysian Family Physician is the official journal of the Academy of Family Physicians of Malaysia. It is published three times a year. Circulation: The journal is distributed free of charge to all members of the Academy of Family Physicians of Malaysia. Complimentary copies are also sent to other organizations that are members of the World Organization of Family Doctors (WONCA).